Jubilant Ingrevia's Stock Sees Positive Performance, Outperforms Sector and Sensex

Jubilant Ingrevia, a midcap pharmaceutical and drugs company, saw a positive performance on October 16th, 2024. The stock gained 5.18% and closed at Rs. 783.75. MarketsMOJO has given a 'Hold' call for the stock.

In terms of price performance, Jubilant Ingrevia outperformed the sector by 5.72% on the same day. The stock has been on a consecutive gain for the last 2 days and has seen a rise of 7.27% during this period. The stock also touched an intraday high of Rs. 787.15, which is a 5.26% increase from the previous day.

Jubilant Ingrevia is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the stock's performance.

In comparison to the Sensex, Jubilant Ingrevia has outperformed with a 1-day performance of 4.81% while the Sensex saw a -0.46% performance. In the last month, Jubilant Ingrevia has seen a 1.63% increase while the Sensex has seen a -1.86% decrease.

Overall, Jubilant Ingrevia has shown a strong performance in the market and is currently trading at a higher level than its moving averages. Investors may want to keep an eye on this midcap company for potential future growth.